|
|
| Line 118: |
Line 118: |
| | <img src="https://static.igem.org/mediawiki/2017/2/2c/T--TokyoTech--logo10011204.jpg" alt="John" style="width:100%"> | | <img src="https://static.igem.org/mediawiki/2017/2/2c/T--TokyoTech--logo10011204.jpg" alt="John" style="width:100%"> |
| | </div> | | </div> |
| | + | |
| | + | <div id="normal_parts_header" class="container_header"> |
| | + | <h1><span>TokyoTech 2017 iGEM Team Parts</span></h1> |
| | + | </div><!-- /normal_parts_header --> |
| | + | <div id="normal_parts_contents" class="container_contents"> |
| | + | <table border="1" align="center" class="parts_table"> |
| | + | <tbody> |
| | + | <tr> |
| | + | <th class="parts_table_name">Name</th> |
| | + | <th class="parts_table_type">Type</th> |
| | + | <th class="parts_table_description">Description</th> |
| | + | <th class="parts_table_design">Design</th> |
| | + | <th class="parts_table_length">Length(bp)</th> |
| | + | </tr> |
| | + | <tr> |
| | + | <td><a href="http://parts.igem.org/Part:BBa_K2505000">BBa_K2505000</a></td> |
| | + | <td>Transrational unit</td> |
| | + | <td><span style="font-style:italic;">rbs-ahk4</span></td> |
| | + | <td>Kohei Umedera</td> |
| | + | <td></td> |
| | + | </tr> |
| | + | |
| | + | <tr> |
| | + | <td><a href="http://parts.igem.org/Part:BBa_K2505002">BBa_K2505002</a></td> |
| | + | <td>Coding</td> |
| | + | <td><span style="font-style:italic;">atIPT4</span></td> |
| | + | <td>Takuma Yasue</td> |
| | + | <td></td> |
| | + | </tr> |
| | + | <tr> |
| | + | <td><a href="http://parts.igem.org/Part:BBa_K2505003">BBa_K2505003</a></td> |
| | + | <td>Transrational unit</td> |
| | + | <td>IVS-IRES-<span style="font-style:italic;">log1</span></td> |
| | + | <td>Hazuki Hasegawa</td> |
| | + | <td></td> |
| | + | </tr> |
| | + | |
| | + | <tr> |
| | + | <td><a href="http://parts.igem.org/Part:BBa_K2505006">BBa_K2505006</a></td> |
| | + | <td>Regulatory</td> |
| | + | <td>P<span style="font-style:italic;">cps-rbs</span>(native)</td> |
| | + | <td>Takuma Yasue</td> |
| | + | <td></td> |
| | + | </tr> |
| | + | |
| | + | <tr> |
| | + | <td><a href="http://parts.igem.org/Part:BBa_K2505033">BBa_K2505033</a></td> |
| | + | <td>Coding</td> |
| | + | <td>traI(34M)</td> |
| | + | <td>Kazunori Motai</td> |
| | + | <td></td> |
| | + | </tr> |
| | + | <tr> |
| | + | <td><a href="http://parts.igem.org/Part:BBa_K2505034">BBa_K2505034</a></td> |
| | + | <td>Coding</td> |
| | + | <td>traI(63M)</td> |
| | + | <td>Kazunori Motai</td> |
| | + | <td></td> |
| | + | </tr> |
| | + | <tr> |
| | + | <td><a href="http://parts.igem.org/Part:BBa_K2505035">BBa_K2505035</a></td> |
| | + | <td>Coding</td> |
| | + | <td>traI(WM)</td> |
| | + | <td>Kazunori Motai</td> |
| | + | <td></td> |
| | + | </tr> |
| | | | |
| − | <!-- Overview -->
| + | </tbody> |
| − | <div class="w3-container" id="overview" style="margin-top:20px; z-index: 3">
| + | </table> |
| − | <h1 class="w3-xxxlarge w3-text-red" style="padding-bottom: 10px;padding-top: 10px"><b>Overview</b></h1>
| + | </div><!-- /normal_parts_contents --> |
| − | <hr style="width:50px;border:5px solid red" class="w3-round"> | + | </div><!-- /parts_2017 --> |
| − | <p style="font-family: Poppins;font-size: 16px">Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public.
| + | |
| − | </p>
| + | |
| | </div> | | </div> |
| | | | |
| Line 130: |
Line 194: |
| | | | |
| | | | |
| − | <!-- Project -->
| |
| − | <div class="w3-container" id="project" style="margin-top:20px">
| |
| − | <h1 class="w3-xxxlarge w3-text-red" style="padding-bottom: 10px;padding-top: 10px"><b>Project </b><a href="https://2017.igem.org/Team:TokyoTech/Project"><button class="w3-button w3-red w3-padding-large w3-hover-black" style="font-size: 25px">Read More</button></a></h1>
| |
| − | <hr style="width:50px;border:5px solid red" class="w3-round">
| |
| − | <p style="font-family: Poppins;font-size: 16px">Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public.
| |
| − | </p>
| |
| − | </div>
| |
| − |
| |
| − | <hr>
| |
| − |
| |
| − | <!-- Modeling -->
| |
| − | <div class="w3-container" id="modeling" style="margin-top:20px">
| |
| − | <h1 class="w3-xxxlarge w3-text-red" style="padding-bottom: 10px;padding-top: 10px"><b>Modeling </b><a href="https://2017.igem.org/Team:TokyoTech/Modeling"><button class="w3-button w3-red w3-padding-large w3-hover-black" style="font-size: 25px">Read More</button></a></h1>
| |
| − | <hr style="width:50px;border:5px solid red" class="w3-round">
| |
| − | <p style="font-family: Poppins;font-size: 16px">Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public.
| |
| − | </p>
| |
| − | </div>
| |
| − |
| |
| − | <hr>
| |
| − |
| |
| − | <!-- Human Practice -->
| |
| − | <div class="w3-container" id="hp" style="margin-top:20px">
| |
| − | <h1 class="w3-xxxlarge w3-text-red" style="padding-bottom: 10px;padding-top: 10px"><b>Human Practices </b><a href="https://2017.igem.org/Team:TokyoTech/Human_Practices"><button class="w3-button w3-red w3-padding-large w3-hover-black" style="font-size: 25px">Read More</button></h1>
| |
| − | <hr style="width:50px;border:5px solid red" class="w3-round">
| |
| − | <p style="font-family: Poppins;font-size: 16px">Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public.
| |
| − | </p>
| |
| − | </div>
| |
| − |
| |
| − | <hr>
| |
| − |
| |
| − | <!-- Notebook -->
| |
| − | <div class="w3-container" id="notebook" style="margin-top:20px">
| |
| − | <h1 class="w3-xxxlarge w3-text-red" style="padding-bottom: 10px;padding-top: 10px"><b>Notebook </b><a href="https://2017.igem.org/Team:TokyoTech/Notebook"><button class="w3-button w3-red w3-padding-large w3-hover-black" style="font-size: 25px">Read More</button></a></h1>
| |
| − | <hr style="width:50px;border:5px solid red" class="w3-round">
| |
| − | <p style="font-family: Poppins;font-size: 16px">Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public.
| |
| − | </p>
| |
| − | </div>
| |
| − |
| |
| − | <hr>
| |
| − |
| |
| − | <!-- Team -->
| |
| − | <div class="w3-container" id="team" style="margin-top:20px">
| |
| − | <h1 class="w3-xxxlarge w3-text-red" style="padding-bottom: 10px;padding-top: 10px"><b>Team </b><a href="https://2017.igem.org/Team:TokyoTech/Team"><button class="w3-button w3-red w3-padding-large w3-hover-black" style="font-size: 25px">Read More</button></a></h1>
| |
| − | <hr style="width:50px;border:5px solid red" class="w3-round">
| |
| − | <p style="font-family: Poppins;font-size: 16px">Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public.
| |
| − | </p>
| |
| − | </div>
| |
| − |
| |
| − | <hr>
| |
| − |
| |
| − | <!-- PAGE CONTENT! -->
| |
| − |
| |
| − | <div class="w3-container" id="contact" style="margin-top:75px">
| |
| − | <img src="https://static.igem.org/mediawiki/2017/2/24/T-TokyoTech--coculture_system.jpg" alt="John" style="width:100%">
| |
| − | </div>
| |
| − |
| |
| − |
| |
| − | <!-- Sponsers -->
| |
| − | <div class="w3-container" id="sponsers" style="margin-top:75px;">
| |
| − | <h1 class="w3-xxxlarge w3-text-red" style="padding-top: 10px;padding-bottom: 10px"><b>Sponsers</b></h1>
| |
| − | <hr style="width:50px;border:5px solid red" class="w3-round">
| |
| − | </div>
| |
| − |
| |
| − | <div class="w3-row-padding">
| |
| − | <div class="w3-col m4 w3-margin-bottom">
| |
| − | <div class="w3-light-grey">
| |
| − | <img src="https://static.igem.org/mediawiki/2016/4/47/Tokyo_Tech_JASSO.gif" style="width:100%">
| |
| − | <div class="w3-container">
| |
| − | <h3>JASSO</h3>
| |
| − | </div>
| |
| − | </div>
| |
| − | </div>
| |
| − | <div class="w3-col m4 w3-margin-bottom">
| |
| − | <div class="w3-light-grey">
| |
| − | <img src="http://kuramae-old.tokyo.r-cms.jp/files/user/common/p_images/head_logo.gif" style="width:100%">
| |
| − | <div class="w3-container">
| |
| − | <h3>Kuramae Kougyoukai</h3>
| |
| − | </div>
| |
| − | </div>
| |
| − | </div>
| |
| − | <div class="w3-col m4 w3-margin-bottom">
| |
| − | <div class="w3-light-grey">
| |
| − | <img src="http://www.vmcs.ucdavis.edu/idt/images/idt-logo.jpg" style="width:100%">
| |
| − | <div class="w3-container">
| |
| − | <h3>IDT</h3>
| |
| − | </div>
| |
| − | </div>
| |
| − | </div>
| |
| − | </div>
| |
| | | | |
| − | <!-- End page content -->
| |
| − | </div>
| |
| | | | |
| | <!-- W3.CSS Container --> | | <!-- W3.CSS Container --> |
